Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / July / IOP Spikes During Hemodialysis
Glaucoma News Research & Innovations

IOP Spikes During Hemodialysis

Researchers identify transient intraocular pressure spikes and falling ocular perfusion during hemodialysis

7/7/2026 2 min read

Share

  • Full Article
  • Summary
  • Listen
  • Scorecard
  • Quiz
  • Poll

Clinical Scorecard: IOP Spikes During Hemodialysis

At a Glance

CategoryDetail
ConditionIntraocular Pressure (IOP) Spikes
Key MechanismsTransient IOP increases during hemodialysis linked to osmotic shifts and ocular perfusion changes.
Target PopulationPatients with end-stage kidney disease (ESKD) undergoing hemodialysis.
Care SettingNephrology and ophthalmology clinics.

Key Highlights

  • Mean IOP increased from 14.9 mmHg to 17.5 mmHg during hemodialysis.
  • Mean ocular perfusion pressure (MOPP) decreased from 56.9 mmHg to 47.2 mmHg.
  • Approximately 25% of eyes experienced a clinically significant IOP rise of more than 5 mmHg.
  • Pre-dialysis serum osmolality above 312 mOsm/kg was a strong predictor of significant IOP rises.
  • Findings suggest a link between hemodialysis and increased glaucoma risk.

Guideline-Based Recommendations

Diagnosis

  • Monitor IOP changes during hemodialysis sessions.

Management

  • Consider pre-dialysis serum osmolality in assessing risk for IOP spikes.

Monitoring & Follow-up

  • Regular ocular assessments for patients with ESKD, especially those with glaucoma or high pre-dialysis osmolality.

Risks

  • Increased risk of ocular perfusion-related injury in patients with diabetic retinopathy or impaired retinal autoregulation.

Patient & Prescribing Data

Patients with end-stage kidney disease on maintenance hemodialysis.

Ocular physiology should be monitored closely during dialysis to prevent potential vision loss.

Clinical Best Practices

  • Collaborate between ophthalmologists and nephrologists to manage ocular health in dialysis patients.
  • Educate patients about the risks of IOP spikes during hemodialysis.

Related Resources & Content

  • Translational Vision Science & Technology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: